HB1638 amends the Illinois Controlled Substances Act to add a new pharmacy-handling requirement for Schedule II controlled substances. Under the bill, if someone other than the patient picks up a Schedule II prescription at a pharmacy, that person must provide identifying information for the patient and present photo identification to the pharmacy.
The pharmacy would be required to keep a photocopy of that photo ID in the patient’s file for 90 days. The bill does not change who may be prescribed Schedule II drugs or the underlying prescribing rules; instead, it creates an additional verification and recordkeeping step at the point of pickup for third-party recipients.
Impact
The bill would modify Section 312 of the Illinois Controlled Substances Act by adding subsection (d-1), creating a new documentation requirement for pharmacies when a Schedule II prescription is collected by someone other than the named patient. Pharmacies would need to collect and retain a copy of the recipient’s photo identification and maintain it in the patient’s file for 90 days, which would affect pharmacy procedures, privacy practices, and record retention obligations. The change would apply specifically to Schedule II controlled substances, which are among the most tightly regulated prescription drugs under Illinois law.
Sentiment
No committee transcripts or recorded votes were provided, so there is no direct evidence of debate, support, or opposition in the available materials. Based on the bill text alone, the measure appears to be framed as a controlled-substance security and verification bill, suggesting a public-safety rationale rather than a broad policy overhaul. The absence of recorded legislative activity makes the overall sentiment difficult to gauge from the provided record.
Contention
The main potential point of contention is the added burden on pharmacies and the privacy implications of copying and retaining photo identification for prescription pickups. Supporters would likely view the requirement as a safeguard against diversion, fraud, or unauthorized pickup of Schedule II medications, while opponents may argue it creates extra administrative work, may inconvenience patients who rely on caregivers or family members, and raises concerns about storing personal identification information. Because no hearing testimony or votes are included, the record does not show which of these concerns were raised by specific lawmakers or stakeholders.